ID: ALA174195

Max Phase: Preclinical

Molecular Formula: C20H23ClN2O2

Molecular Weight: 358.87

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NC1CN2CCC1CC2)c1cc(Cl)cc2c3c(oc12)CCCC3

Standard InChI:  InChI=1S/C20H23ClN2O2/c21-13-9-15-14-3-1-2-4-18(14)25-19(15)16(10-13)20(24)22-17-11-23-7-5-12(17)6-8-23/h9-10,12,17H,1-8,11H2,(H,22,24)

Standard InChI Key:  IRZRAMWZPYYODF-UHFFFAOYSA-N

Associated Targets(non-human)

Mustela putorius furo 1007 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.87Molecular Weight (Monoisotopic): 358.1448AlogP: 3.79#Rotatable Bonds: 2
Polar Surface Area: 45.48Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.90CX LogP: 3.40CX LogD: 2.78
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.89Np Likeness Score: -0.54

References

1. Youssefyeh RD, Campbell HF, Airey JE, Klein S, Schnapper M, Powers M, Woodward R, Rodriguez W, Golec S, Studt W..  (1992)  Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.,  35  (5): [PMID:1548679] [10.1021/jm00083a015]

Source